Healthcare’s AI Problem Isn’t Scarcity Anymore—It’s Control
Northeastern Global News frames a growing concern across the industry: AI use in healthcare is proliferating faster than institutions can govern it. The resulting challenge is less about whether AI will be used and more about how health systems can impose standards, accountability and boundaries after the tools have already spread.
The phrase that AI is 'running rampant' in healthcare captures an uncomfortable truth: deployment is no longer confined to formal enterprise rollouts. Clinicians, administrators, researchers and staff can access general-purpose AI tools directly, which means the governance problem now extends far beyond approved vendor contracts.
This is a major shift from earlier phases of healthcare digitization. Traditional health IT adoption was relatively centralized—procurement teams, compliance reviews and IT departments mediated access. Generative AI breaks that model because powerful tools are available instantly, often outside institutional oversight. That creates risks around privacy, misinformation, inconsistent use and undocumented influence on care decisions.
The likely response will be a new layer of operational governance. Health systems may need approved-use policies, internal model registries, monitoring programs and education efforts aimed not only at physicians but at the full healthcare workforce. In effect, AI governance is becoming an enterprise management discipline, not merely a technical or legal function.
This is why the current moment feels different. The question is no longer whether organizations should have an AI strategy. It is whether they can establish control quickly enough to channel inevitable use into safe, auditable and clinically defensible pathways.